FOURIER: Extensive Lipid Lowering (PCSK9)

How should a practitioner apply the evidence from the FOURIER trial? This course explains how targeted treatment at PCSK9 inhibition confers additional cardiovascular benefits beyond lipid-lowering treatment alone.

Target Audience

Cardiologists, General Internists, Family Physicians, Emergency Medicine and Urgent Care Physicians, Obstetricians, Gynecologists and Physician Assistants.

Learning Objective

  • Examine the formal evidence from the FOURIER trial, and explain how targeted treatment at PCSK9 inhibition confers additional cardiovascular benefits beyond lipid-lowering treatment alone.
Additional information
Bibliography: 
  • Shah, S. R., Uddin, M. F., Lateef, N., Dharani, A. M., Shahnawaz, W., Kazi, A. N., & Shah, S. A. (2017). Evolocumab to reduce cardiovascular events: results of the (FOURIER) multinational trial. Journal of community hospital internal medicine perspectives, 7(3), 199.
Course Summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 General certificate of attendance
Course opens: 
04/01/2018
Course expires: 
04/01/2019
Rating: 
0

Christie M. Ballantyne, M.D.
Vice-chair, Research, Department of Medicine
Chief, Cardiology and Cardiovascular Research
Director, Center for Cardiometabolic Disease Prevention’s Lipid Metabolism and Atherosclerosis Clinic
Baylor College of Medicine
Houston, Texas

Christie M. Ballantyne, M.D., has disclosed that he receives grant/research support from Abbott Diagnostic, Amarin, Amgen, Esperion, Ionis, Novartis Pharmaceuticals, Pfizer Pharmaceuticals, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, National Institutes of Health, American Heart Association and American Diabetes Association. Also, Dr. Ballantyne serves as a consultant to Abbott Diagnostic, Amarin, Amgen, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Eli Lilly, Esperion, Ionis, Matinas BioPharma, Inc., Merck, Novartis Pharmaceuticals, Novo Nordisk, Pfizer Pharmaceuticals, Regeneron, Roche Diagnostic and Sanofi-Synthelabo. Dr. Ballantyne has disclosed that his presentations will include discussion of off-label or unapproved usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
             
Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 General certificate of attendance
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet.
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play.
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions”.

Apple Computers Running OSX

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.